Purification and identification of a polysaccharide from medicinal mushroom Amauroderma rude with immunomodulatory activity and inhibitory effect on tumor growth
Metrics: PDF 1865 views | HTML 1606 views | ?
Honghui Pan1, Yuanyuan Han1, Jiguo Huang1, Xiongtao Yu1, Chunwei Jiao2, Xiaobing Yang1, Preet Dhaliwal3,4, Yizhen Xie1, Burton B. Yang3,4
1Guangdong Institute of Microbiology, State Key Laboratory of Applied Microbiology Southern China, Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, Guangdong Open Laboratory of Applied Microbiology, Guangzhou, China
2Yuewei Edible Fungi Technology Co. Ltd., Guangzhou, China
3Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada
4Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
Yizhen Xie, e-mail: firstname.lastname@example.org
Burton B. Yang, e-mail: email@example.com
Keywords: medicinal mushroom, herbal medicine, tumor growth, cytokine, amauroderma
Received: April 28, 2015 Accepted: June 15, 2015 Published: June 27, 2015
Medicinal mushrooms in recent years have been the subject of many experiments searching for anticancer properties. We previously screened thirteen mushrooms for their potential in inhibiting tumor growth, and found that the water extract of Amauroderma rude exerted the highest activity. Previous studies have shown that the polysaccharides contained in the water extract were responsible for the anticancer properties. This study was designed to explore the potential effects of the polysaccharides on immune regulation and tumor growth. Using the crude Amauroderma rude extract, in vitro experiments showed that the capacities of spleen lymphocytes, macrophages, and natural killer cells were all increased. In vivo experiments showed that the extract increased macrophage metabolism, lymphocyte proliferation, and antibody production. In addition, the partially purified product stimulated the secretion of cytokines in vitro, and in vivo. Overall, the extract decreased tumor growth rates. Lastly, the active compound was purified and identified as polysaccharide F212. Most importantly, the purified polysaccharide had the highest activity in increasing lymphocyte proliferation. In summary, this molecule may serve as a lead compound for drug development.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.